Ten vs five years of bisphosphonate treatment for postmenopausal osteoporosis: enough of a good thing. [electronic resource]
- JAMA Dec 2006
- 2968-9 p. digital
Publication Type: Comment; Editorial
1538-3598
10.1001/jama.296.24.2968 doi
Aged Alendronate--therapeutic use Bone Density--drug effects Bone Density Conservation Agents--therapeutic use Female Fractures, Bone--epidemiology Humans Osteoporosis, Postmenopausal--drug therapy